These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26487442)

  • 1. Computational allosteric ligand binding site identification on Ras proteins.
    McCarthy M; Prakash P; Gorfe AA
    Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):3-10. PubMed ID: 26487442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of conserved waters in conformational transitions of Q61H K-ras.
    Prakash P; Sayyed-Ahmad A; Gorfe AA
    PLoS Comput Biol; 2012; 8(2):e1002394. PubMed ID: 22359497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of binding site hot spots on the surface of Ras GTPase.
    Buhrman G; O'Connor C; Zerbe B; Kearney BM; Napoleon R; Kovrigina EA; Vajda S; Kozakov D; Kovrigin EL; Mattos C
    J Mol Biol; 2011 Nov; 413(4):773-89. PubMed ID: 21945529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C.
    Hunter JC; Gurbani D; Ficarro SB; Carrasco MA; Lim SM; Choi HG; Xie T; Marto JA; Chen Z; Gray NS; Westover KD
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8895-900. PubMed ID: 24889603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can We Rely on Computational Predictions To Correctly Identify Ligand Binding Sites on Novel Protein Drug Targets? Assessment of Binding Site Prediction Methods and a Protocol for Validation of Predicted Binding Sites.
    Broomhead NK; Soliman ME
    Cell Biochem Biophys; 2017 Mar; 75(1):15-23. PubMed ID: 27796788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding hotspots on K-ras: consensus ligand binding sites and other reactive regions from probe-based molecular dynamics analysis.
    Prakash P; Hancock JF; Gorfe AA
    Proteins; 2015 May; 83(5):898-909. PubMed ID: 25740554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPC Analysis of Multiple Binding Sites Communication and Allosteric Modulations in Drug Design: The HSP Case Study.
    Chiappori F; Milanesi L; Merelli I
    Curr Drug Targets; 2016; 17(14):1610-1625. PubMed ID: 26648062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pMD-Membrane: A Method for Ligand Binding Site Identification in Membrane-Bound Proteins.
    Prakash P; Sayyed-Ahmad A; Gorfe AA
    PLoS Comput Biol; 2015 Oct; 11(10):e1004469. PubMed ID: 26506102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational approach to de novo discovery of fragment binding for novel protein states.
    Konteatis ZD; Klon AE; Zou J; Meshkat S
    Methods Enzymol; 2011; 493():357-80. PubMed ID: 21371598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shift in the equilibrium between on and off states of the allosteric switch in Ras-GppNHp affected by small molecules and bulk solvent composition.
    Holzapfel G; Buhrman G; Mattos C
    Biochemistry; 2012 Aug; 51(31):6114-26. PubMed ID: 22845804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ensemble Docking in Drug Discovery: How Many Protein Configurations from Molecular Dynamics Simulations are Needed To Reproduce Known Ligand Binding?
    Evangelista Falcon W; Ellingson SR; Smith JC; Baudry J
    J Phys Chem B; 2019 Jun; 123(25):5189-5195. PubMed ID: 30695645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards the identification of the allosteric Phe-binding site in phenylalanine hydroxylase.
    Carluccio C; Fraternali F; Salvatore F; Fornili A; Zagari A
    J Biomol Struct Dyn; 2016; 34(3):497-507. PubMed ID: 26479306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs.
    Platania CBM; Bucolo C
    Methods Mol Biol; 2021; 2253():245-254. PubMed ID: 33315227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the nucleotide and isoform-dependent structural and dynamical features of Ras proteins.
    Gorfe AA; Grant BJ; McCammon JA
    Structure; 2008 Jun; 16(6):885-96. PubMed ID: 18547521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel scaffolds to inhibit human mitotic kinesin Eg5 targeting the second allosteric binding site using in silico methods.
    Makala H; Ulaganathan V
    J Recept Signal Transduct Res; 2018 Feb; 38(1):12-19. PubMed ID: 29041840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel allosteric sites on Ras for lead generation.
    Grant BJ; Lukman S; Hocker HJ; Sayyah J; Brown JH; McCammon JA; Gorfe AA
    PLoS One; 2011; 6(10):e25711. PubMed ID: 22046245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Rab1 binding sites using an ensemble of clustering methods.
    Lukman S; Nguyen MN; Sim K; Teo JC
    Proteins; 2017 May; 85(5):859-871. PubMed ID: 28120477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent computational advances in the identification of allosteric sites in proteins.
    Lu S; Huang W; Zhang J
    Drug Discov Today; 2014 Oct; 19(10):1595-600. PubMed ID: 25107670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational ensembles, signal transduction and residue hot spots: application to drug discovery.
    Acuner Ozbabacan SE; Gursoy A; Keskin O; Nussinov R
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):527-37. PubMed ID: 20812144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Dynamics Simulation and Prediction of Druggable Binding Sites.
    Feng T; Barakat K
    Methods Mol Biol; 2018; 1762():87-103. PubMed ID: 29594769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.